Desnick RJ, Blieden LC, Sharp HL, Hofschire PJ, Moller JH. Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation. 1976;54(5):818–25.

Article  CAS  PubMed  Google Scholar 

Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003;138(4):338–46.

Article  PubMed  Google Scholar 

Mehta A, Beck M, Eyskens F, Feliciani C, Kantola I, Ramaswami U, et al. Fabry disease: a review of current management strategies. QJM. 2010;103(9):641–59.

Article  CAS  PubMed  Google Scholar 

Niemann M, Herrmann S, Hu K, Breunig F, Strotmann J, Beer M, et al. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment. JACC Cardiovasc Imaging. 2011;4(6):592–601.

Article  PubMed  Google Scholar 

Nair V, Belanger EC, Veinot JP. Lysosomal storage disorders affecting the heart: a review. Cardiovasc Pathol. 2019;39:12–24.

Article  CAS  PubMed  Google Scholar 

Namdar M. Electrocardiographic changes and arrhythmia in Fabry disease. Front Cardiovasc Med. 2016;3:7.

Article  PubMed  PubMed Central  Google Scholar 

Shah JS, Hughes DA, Sachdev B, Tome M, Ward D, Lee P, et al. Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease. Am J Cardiol. 2005;96(6):842–6.

Article  PubMed  Google Scholar 

Krämer J, Niemann M, Störk S, Frantz S, Beer M, Ertl G, et al. Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease. Am J Cardiol. 2014;114(6):895–900.

Article  PubMed  Google Scholar 

Acharya D, Robertson P, Kay GN, Jackson L, Warnock DG, Plumb VJ, et al. Arrhythmias in Fabry cardiomyopathy. Clin Cardiol. 2012;35(12):738–40.

Article  PubMed  PubMed Central  Google Scholar 

Frustaci A, Morgante E, Russo MA, Scopelliti F, Grande C, Verardo R, et al. Pathology and function of conduction tissue in Fabry disease cardiomyopathy. Circ Arrhythm Electrophysiol. 2015;8(4):799–805.

Article  CAS  PubMed  Google Scholar 

Deva DP, Hanneman K, Li Q, Ng MY, Wasim S, Morel C, et al. Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease. J Cardiovasc Magn Reson. 2016;18:14.

Article  PubMed  PubMed Central  Google Scholar 

Patel V, O’Mahony C, Hughes D, Rahman MS, Coats C, Murphy E, et al. Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry disease. Heart. 2015;101(12):961–6.

Article  PubMed  Google Scholar 

Weidemann F, Maier SK, Störk S, Brunner T, Liu D, Hu K, et al. Usefulness of an implantable loop recorder to detect clinically relevant arrhythmias in patients with advanced fabry cardiomyopathy. Am J Cardiol. 2016;118(2):264–74.

Article  PubMed  Google Scholar 

• Orsborne C, Bradley J, Bonnett LJ, Pleva LA, Naish JH, Clark DG, et al. Validated model for prediction of adverse cardiac outcome in patients with Fabry disease. J Am Coll Cardiol. 2022;80(10):982–94. This important studyhighlights how risk-prediction for arrhythmia can be accurately modelled in Fabry disease using advance cardiac magnetic resonance techniques but requires further external validation.

Article  PubMed  Google Scholar 

•• Meucci MC, Lillo R, Del Franco A, Monda E, Iannaccone G, Baldassarre R, et al. Prognostic implications of the extent of cardiac damage in patients with Fabry disease. J Am Coll Cardiol. 2023;82(15):1524–34. This study highlights how risk prediction formajor adverse cardiac events including arrhythmia can be evaluated using conventional transthoracic echocardiography which patients with FD will undergo routinely as part of their clinical care.

Article  PubMed  Google Scholar 

Vijapurapu R, Geberhiwot T, Jovanovic A, Baig S, Nordin S, Kozor R, et al. Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy. Heart. 2019;105(23):1825–31.

Article  CAS  PubMed  Google Scholar 

Pelliccia F, Pasceri V, Limongelli G, Autore C, Basso C, Corrado D, et al. Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis. Int J Cardiol. 2017;243:379–84.

Article  PubMed  Google Scholar 

Elliott PM, Gimeno JR, Thaman R, Shah J, Ward D, Dickie S, et al. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart. 2006;92(6):785–91.

Article  CAS  PubMed  Google Scholar 

Weidemann F, Niemann M, Störk S, Breunig F, Beer M, Sommer C, et al. Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J Intern Med. 2013;274(4):331-41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Germain DP, Brand E, Burlina A, Cecchi F, Garman SC, Kempf J, et al. Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: a multicenter Fabry Registry study. Mol Genet Genomic Med. 2018.

•• Vijapurapu R, Roy A, Demetriades P, Warfield A, Hughes DA, Moon J, et al. Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease. Open Heart. 2023;10(2). This review assessing atrial fibrillation and bradycardia requiring device implantation concludes that whilst reporting of both are limited to single-centre studies and have variable reporting dependent on diagnostic modality, the burden of brady-arrhythmia and atrial fibrillation requiring therapy are likely to be much higher than reported. Factors such as left ventricular hypertrophy, age and atrial volume dilatation may contribute to the burden of arrhythmia.

Hagège A, Réant P, Habib G, Damy T, Barone-Rochette G, Soulat G, et al. Fabry disease in cardiology practice: literature review and expert point of view. Arch Cardiovasc Dis. 2019;112(4):278–87.

Article  PubMed  Google Scholar 

Lobo T, Morgan J, Bjorksten A, Nicholls K, Grigg L, Centra E, et al. Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement. Intern Med J. 2008;38(6):407–14.

Article  CAS  PubMed  Google Scholar 

Wilson HC, Hopkin RJ, Madueme PC, Czosek RJ, Bailey LA, Taylor MD, et al. Arrhythmia and clinical cardiac findings in children with Anderson-Fabry disease. Am J Cardiol. 2017;120(2):251–5.

Article  PubMed  Google Scholar 

Di LZ, Pichette M, Nadeau R, Bichet DG, Poulin F. Severe bradyarrhythmia linked to left atrial dysfunction in Fabry disease—a cross-sectional study. Clin Cardiol. 2018;41(9):1207–13.

Article  PubMed  PubMed Central  Google Scholar 

O’Mahony C, Coats C, Cardona M, Garcia A, Calcagnino M, Murphy E, et al. Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease. Europace. 2011;13(12):1781–8.

Article  PubMed  Google Scholar 

Sené T, Lidove O, Sebbah J, Darondel JM, Picard H, Aaron L, et al. Cardiac device implantation in Fabry disease: a retrospective monocentric study. Medicine (Baltimore). 2016;95(40): e4996.

Article  PubMed  Google Scholar 

Pichette M, Serri K, Pagé M, Di LZ, Bichet DG, Poulin F. Impaired left atrial function in Fabry disease: a longitudinal speckle-tracking echocardiography study. J Am Soc Echocardiogr. 2017;30(2):170-9.e2.

Article  PubMed  Google Scholar 

Talbot AS, Lewis NT, Nicholls KM. Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease. Heart. 2015;101(4):287–93.

Article  PubMed  Google Scholar 

Fan JL, Su B, Zhao X, Zhou BY, Ma CS, Wang HP, et al. Correlation of left atrial strain with left ventricular end-diastolic pressure in patients with normal left ventricular ejection fraction. Int J Cardiovasc Imaging. 2020;36(9):1659–66.

Article  PubMed  PubMed Central  Google Scholar 

Hauser R, Nielsen AB, Skaarup KG, Lassen MCH, Duus LS, Johansen ND, et al. Left atrial strain predicts incident atrial fibrillation in the general population: the Copenhagen City Heart Study. Eur Heart J Cardiovasc Imaging. 2021;23(1):52–60.

Article  PubMed  Google Scholar 

Fukuda Y, Onishi T, Suzuki A, Tanaka H, Fukuzawa K, Yoshida A, et al. Follow-up of cardiac fabry disease treated by cardiac resynchronization therapy. CASE (Phila). 2017;1(4):134–7.

PubMed  Google Scholar 

Roy A, Vijapurapu R, Kurdi H, Orsborne C, Woolfson P, Kalla M, et al. Clinical utilisation of implantable loop recorders in adults with Fabry disease—a multi-centre snapshot study. Front Cardiovasc Med. 2023;10:1323214.

Article  PubMed  PubMed Central  Google Scholar 

Hiwot T, Hughes D, Ramaswami U. Guidelines for the treatment of Fabry disease. British Inherited Metabolic Diseases Group2020.

Arends M, Wanner C, Hughes D, Mehta A, Oder D, Watkinson OT, et al. Characterization of classical and nonclassical fabry disease: a multicenter study. J Am Soc Nephrol. 2017;28(5):1631–41.

Article  CAS  PubMed  Google Scholar 

Vijapurapu R, Bradlow W, Leyva F, Moon JC, Zegard A, Lewis N, et al. Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy. Orphanet J Rare Dis. 2022;17(1):6.

Article  PubMed  PubMed Central  Google Scholar 

Vijapurapu R, Kozor R, Hughes DA, Woolfson P, Jovanovic A, Deegan P, et al. A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice. Trials. 2019;20(1):314.

Article  PubMed  PubMed Central  Google Scholar 

Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry’s disease. Ceramidetrihexosidase deficiency N Engl J Med. 1967;276(21):1163–7.

Article  CAS  PubMed  Google Scholar 

Namdar M, Steffel J, Vidovic M, Brunckhorst CB, Holzmeister J, Lüscher TF, et al. Electrocardiographic changes in early recognition of Fabry disease. Heart. 2011;97(6):485–90.

Article  PubMed